Autism Spectrum Disorder Asd clinical trials

Explore recruiting autism spectrum disorder asd clinical trials.

Recruiting autism spectrum disorder asd studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Autism Spectrum Disorder Asd trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ALaDIN - Use of low doses of interleukin-2 in autism spectrum disorders

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Enhancing social attunement in autism via interpersonal sensorimotor synchronization therapy combined with single-dose intranasal oxytocin administration

Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

Evaluation of oxytocin treatment in children with autism and intellectual disability’, Multiple-dose Oxytocine - ASD and Intellectual Disability

Belgium

Phase III and phase IV (Integrated) EU CTIS Study details

Enhancing social attunement in autism via interpersonal sensorimotor synchronization therapy combined with single-dose intranasal oxytocin administration

Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

A 52-Week Open-Label Extension Study of Pimavanserin in Children and Adolescents with Irritability Associated with Autism Spectrum Disorder (ASD)

Spain, Poland, France, Italy, Hungary

Therapeutic exploratory (Phase II) EU CTIS Study details

An open label safety and efficacy study of allogenic adipose tissue-derived mesenchymal stromal cells on autism and gastrointestinal symptoms

Denmark

Human Pharmacology (Phase I)- Other EU CTIS Study details

Autism Spectrum Disorder Asd trials by city

Autism Spectrum Disorder Asd in Toronto Autism Spectrum Disorder Asd in Vancouver Autism Spectrum Disorder Asd in Montreal Autism Spectrum Disorder Asd in Calgary Autism Spectrum Disorder Asd in Edmonton Autism Spectrum Disorder Asd in Ottawa Autism Spectrum Disorder Asd in Winnipeg Autism Spectrum Disorder Asd in Quebec City Autism Spectrum Disorder Asd in Hamilton Autism Spectrum Disorder Asd in Kitchener Autism Spectrum Disorder Asd in London Autism Spectrum Disorder Asd in Halifax Autism Spectrum Disorder Asd in New York Autism Spectrum Disorder Asd in Los Angeles Autism Spectrum Disorder Asd in Chicago Autism Spectrum Disorder Asd in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease